Jesus Baena

BD&L Transactions Oncology Director at Novartis

Speaker

As of January 1 2023, Jesus Baena has been appointed BD&L Transactions Director with focus in oncology.

Since 2020, Jesus was the Director BD&L Oncology at Novartis. He was responsible for external innovation opportunities in Oncology's focus areas of genitourinary and gastrointestinal cancers.

Jesus joined Novartis in 2017, where he held different regional / global positions within the Global Business Development & Licensing department.

Prior to joining Novartis, Jesus worked in the Business Development & Alliance Management department of Pint-Pharma GmbH, a biotech company focused on building its portfolio through external innovation in oncology, rare disease and specialty care; and before that in the Business Development & Alliance Management department for Novellus Biopharma AG, a start-up company focused on development therapies in oncology and rare diseases.